Connable Office Inc Astrazeneca PLC Transaction History
Connable Office Inc
- $957 Million
- Q4 2024
A detailed history of Connable Office Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Connable Office Inc holds 21,178 shares of AZN stock, worth $1.56 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
21,178
Previous 21,763
2.69%
Holding current value
$1.56 Million
Previous $1.7 Million
18.17%
% of portfolio
0.14%
Previous 0.17%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...